AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 12, 2004
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE TRANSITION PERIOD FROM ___________________ TO _____________
COMMISSION FILE NUMBER 0-14669
THE ARISTOTLE CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE |
06-1165854 |
(STATE OR OTHER JURISDICTION OF |
(I.R.S. EMPLOYER |
INCORPORATION OR ORGANIZATION) |
IDENTIFICATION NO.) |
96 CUMMINGS POINT ROAD, STAMFORD, CONNECTICUT
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
06902
(ZIP CODE)
(203) 358-8000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
As of November 10, 2004, 17,130,354 shares of Common Stock, 1,096,622 shares of Series I Preferred Stock and 10,984,971 shares of Series J Preferred Stock were outstanding.
THE ARISTOTLE CORPORATION
INDEX OF INFORMATION CONTAINED IN FORM 10-Q FOR THE
QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004
PART I - FINANCIAL INFORMATION |
||||
Item 1. |
Financial Statements |
|||
Condensed Consolidated Balance Sheets at September 30, 2004 (unaudited), |
||||
December 31, 2003 and September 30, 2003 (unaudited) |
1 |
|||
Condensed Consolidated Statements of Earnings for the Three and Nine |
||||
Months ended September 30, 2004 and 2003 (unaudited) |
2 |
|||
Condensed Consolidated Statements of Cash Flows for the Nine Months |
||||
ended September 30, 2004 and 2003 (unaudited) |
3 |
|||
Notes to Condensed Consolidated Financial Statements (unaudited) |
4 |
|||
Item 2. |
Management's Discussion and Analysis of Financial Condition and |
|||
Results of Operations |
10 |
|||
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
17 |
||
Item 4. |
Controls and Procedures |
18 |
||
PART II - OTHER INFORMATION |
||||
Item 6. |
Exhibits |
19 |
||
PART I
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
Assets |
September 30, 2004 |
December 31, 2003 |
September 30, 2003 |
||||||
(unaudited) |
(unaudited) |
||||||||
Current assets: |
|||||||||
Cash and cash equivalents |
$ |
4,219 |
5,566 |
7,058 |
|||||
Investments |
1,016 |
- |
- |
||||||
Accounts receivable, net |
23,070 |
11,881 |
22,109 |
||||||
Inventories |
33,348 |
29,157 |
29,804 |
||||||
Prepaid expenses and other |
3,912 |
5,598 |
5,777 |
||||||
Refundable income taxes |
- |
344 |
- |
||||||
Deferred income taxes |
9,292 |
8,184 |
7,251 |
||||||
Total current assets |
74,857 |
60,730 |
71,999 |
||||||
Property, plant and equipment, net |
17,256 |
17,340 |
16,855 |
||||||
Goodwill |
13,530 |
11,509 |
10,908 |
||||||
Deferred income taxes |
10,952 |
15,081 |
16,743 |
||||||
Other assets |
526 |
454 |
321 |
||||||
Total assets |
$ |
117,121 |
105,114 |
116,826 |
|||||
Liabilities and Stockholders' Equity |
|||||||||
Current liabilities: |
|||||||||
Current installments of long-term debt |
$ |
105 |
1,415 |
1,541 |
|||||
Trade accounts payable |
9,320 |
5,874 |
8,889 |
||||||
Accrued expenses |
5,981 |
4,537 |
4,148 |
||||||
Accrued dividends payable |
- |
2,154 |
- |
||||||
Income taxes |
245 |
- |
680 |
||||||
Total current liabilities |
15,651 |
13,980 |
15,258 |
||||||
Long-term debt, less current installments |
32,880 |
31,290 |
41,356 |
||||||
Stockholders' equity: |
|||||||||
Preferred stock, Series I, convertible, voting, 11% cumulative, $6.00 |
|||||||||
stated value; $.01 par value; 2,400,000 shares authorized, 1,096,622, |
|||||||||
1,068,622 and 1,053,122 shares issued and outstanding at September |
|||||||||
30, 2004, December 31, 2003 and September 30, 2003, respectively |
6,580 |
6,412 |
6,319 |
||||||
Preferred stock, Series J, non-voting, 12% cumulative, $6.00 stated value; |
|||||||||
$.01 par value; 11,200,000 shares authorized, 10,984,971 shares |
|||||||||
issued and outstanding |
65,760 |
65,760 |
65,760 |
||||||
Common stock, $.01 par value; 20,000,000 shares authorized, 17,129,354, |
|||||||||
17,082,354 and 17,046,854 shares issued and outstanding at |
|||||||||
September 30, 2004, December 31, 2003 and September 30, 2003, |
|||||||||
respectively |
171 |
171 |
170 |
||||||
Additional paid-in capital |
1,288 |
860 |
668 |
||||||
Accumulated deficit |
(5,315) |
(13,257) |
(12,569) |
||||||
Accumulated other comprehensive earnings (loss) |
106 |
(102) |
(136) |
||||||
Total stockholders' equity |
68,590 |
59,844 |
60,212 |
||||||
Total liabilities and stockholders' equity |
$ |
117,121 |
105,114 |
116,826 |
The accompanying notes are an integral part of these condensed consolidated financial statements
.1
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(in thousands, except share and per share data)
(Unaudited)
Three Months Ended |
Nine Months Ended |
|||||||||
September 30, |
September 30, |
|||||||||
2004 |
2003 |
2004 |
2003 |
|||||||
Net sales |
$ |
55,368 |
51,953 |
139,000 |
130,355 |
|||||
Cost of sales |
35,199 |
32,592 |
86,811 |
81,529 |
||||||
Gross profit |
20,169 |
19,361 |
52,189 |
48,826 |
||||||
Selling and administrative expense |
10,885 |
10,319 |
31,170 |
30,437 |
||||||
Earnings from operations |
9,284 |
9,042 |
21,019 |
18,389 |
||||||
Other expense (income): |
||||||||||
Interest expense |
292 |
452 |
894 |
1,131 |
||||||
Other, net |
(41) |
(10) |
(20) |
(65) |
||||||
251 |
442 |
874 |
1,066 |
|||||||
Earnings before income taxes |
9,033 |
8,600 |
20,145 |
17,323 |
||||||
Income taxes: |
||||||||||
Current |
1,004 |
821 |
2,038 |
1,800 |
||||||
Deferred |
411 |
2,572 |
3,686 |
5,018 |
||||||
1,415 |
3,393 |
5,724 |
6,818 |
|||||||
Net earnings |
7,618 |
5,207 |
14,421 |
10,505 |
||||||
Preferred dividends |
2,158 |
2,150 |
6,479 |
6,450 |
||||||
Net earnings applicable to common stockholders |
$ |
5,460 |
3,057 |
7,942 |
4,055 |
|||||
Earnings per common share: |
||||||||||
Basic |
$ |
.32 |
.18 |
.46 |
.24 |
|||||
Diluted |
$ |
.32 |
.18 |
.46 |
.24 |
|||||
Weighted average common shares outstanding: |
||||||||||
Basic |
17,120,573 |
17,033,069 |
17,110,431 |
17,032,153 |
||||||
Diluted |
17,330,679 |
17,206,851 |
17,298,250 |
17,164,339 |
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
Nine Months Ended |
||||||||||
September 30, |
||||||||||
2004 |
2003 |
|||||||||
Cash flows from operating activities: |
||||||||||
Net earnings |
$ |
14,421 |
10,505 |
|||||||
Adjustments to reconcile net earnings to net cash |
||||||||||
provided by operating activities: |
||||||||||
Depreciation and amortization |
1,348 |
1,336 |
||||||||
Stock option compensation |
369 |
397 |
||||||||
Loss on sale of property, plant and equipment |
7 |
17 |
||||||||
Deferred income taxes |
3,686 |
5,018 |
||||||||
Change in assets and liabilities, net of effects of acquired businesses: |
||||||||||
Accounts receivable |
(11,189) |
(9,211) |
||||||||
Inventories |
(3,210) |
(910) |
||||||||
Prepaid expenses and other |
1,686 |
2,104 |
||||||||
Other assets |
(7) |
109 |
||||||||
Trade accounts payable |
3,238 |
3,202 |
||||||||
Accrued expenses and other liabilities |
2,241 |
(457) |
||||||||
Net cash provided by operating activities |
12,590 |
12,110 |
||||||||
Cash flows from investing activities: |
||||||||||
Purchases of property, plant and equipment |
(1,169) |
(3,516) |
||||||||
Proceeds from the sale of property, plant and equipment |
2 |
7 |
||||||||
Change in investments |
(1,016) |
- |
||||||||
Cash paid for acquisitions, net of cash acquired |
(3,729) |
(3,449) |
||||||||
Net cash used in investing activities |
(5,912) |
(6,958) |
||||||||
Cash flows from financing activities: |
||||||||||
Proceeds from issuance of long-term debt |
9,500 |
4,410 |
||||||||
Principal payments on long-term debt |
(9,104) |
(5,262) |
||||||||
Proceeds from issuance of stock under stock option plans |
212 |
59 |
||||||||
Preferred dividends paid |
(8,633) |
(8,600) |
||||||||
Net cash used in financing activities |
(8,025) |
(9,393) |
||||||||
Net decrease in cash and cash equivalents |
(1,347) |
(4,241) |
||||||||
Cash and cash equivalents at beginning of period |
5,566 |
11,299 |
||||||||
Cash and cash equivalents at end of period |
$ |
4,219 |
7,058 |
|||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
The Aristotle Corporation ("Aristotle") and its subsidiaries (together with Aristotle, the "Company"), founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products. A selection of over 80,000 items is offered, primarily through 47 separate catalogs carrying the brand of Nasco (founded in 1941), as well as those bearing the brands of Life/Form, Whirl-Pak(R), Simulaids, Triarco, Summit Learning, Hubbard Scientific, Scott Resources, Spectrum Educational Supplies, Haan Crafts, To-Sew, CPR Prompt(R) and Ginsberg Scientific. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials and items for the agricultural, senior care and food industries. In addition, the Company offers simulation kits and manikins used for training in cardiopulmonary resuscitation and the fire and emergency rescue and patient care fields. The Company also markets proprietary product li nes that provide exclusive distribution rights throughout all of its catalogs. The proprietary product lines are developed internally through the Company's research and development efforts and acquired externally by licensing rights from third parties. The Company's inventories primarily consist of finished goods and catalog merchandise.
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with
accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Condensed Consolidated Financial Statements do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of September 30, 2004 and 2003, results of operations for the three and nine months ended September 30, 2004 and 2003 and cash flows for the nine months ended September 30, 2004 and 2003, as applicable, have been made. Operating results for the three and nine months ended September 30, 2004 are not necessarily indicative of results that may be expected for any other interim period or for the year ending December 31, 2004. For further information, refer to the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2003.All significant intercompany balances and transactions have been eliminated in consolidation.
In December 2003, the Financial Accounting Standards Board issued a revised Interpretation No. 46, Consolidation of Variable Interest Entities ("Interpretation 46R"), which addresses how a business enterprise should evaluate whether it has a controlling financial interest in an entity through means other than voting rights and accordingly should consolidate the entity. Interpretation 46R replaces Interpretation No. 46, Consolidation of Variable Interest Entities, which was issued in January 2003. The Company is required to apply Interpretation 46R to interests in variable interest entities ("VIE") created after December 31, 2003. For variable interests in VIEs created before January 1, 2004, the interpretation will be applied beginning on January 1, 2005. For any VIEs that must be consolidated under Interpretation 46R that were created before January 1, 2004, the assets, liabilities and noncontrolling interests of the VIE initially would be measure d at their carrying amounts with any difference between the net amount added to the balance sheet and any previously recognized interest being recognized as the cumulative effect of an accounting change. If determining the carrying amounts is not practicable, fair value at the date Interpretation 46R first applies may be used to measure the assets, liabilities and noncontrolling interest of the VIE. The adoption of Interpretation 46R did not have a material impact on the Company's financial statements for the three and nine months ended September 30, 2004.
4
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
On September 17, 2004, Aristotle purchased certain assets of the science product line of Ginsberg Scientific Company and GSC International, Inc. (collectively referred to as "Ginsberg") for $1.8 million. Ginsberg is a manufacturer and distributor of products and kits designed to demonstrate certain science concepts for students in grades 5-12. The Ginsberg offerings complement the science product lines currently manufactured and distributed by the Company in the educational segment. The results of Ginsberg's operations have been included in the Company's consolidated financial statements since the date of such acquisition. The purchase price allocation resulted in goodwill of $1.0 million attributable to the educational segment.
On August 11, 2004, Aristotle purchased certain assets of the CPR Prompt product line from Cardiac Science, Inc. for $1.9 million. The CPR Prompt product line is comprised of a number of products, primarily training manikins, used in the instruction of cardiopulmonary resuscitation. The CPR Prompt product line complements product lines currently manufactured and distributed by the Company in the educational segment. The results of CPR Prompt's operations have been included in the Company's consolidated financial statements since the date of such acquisition. The purchase price allocation resulted in goodwill of $1.0 million attributable to the educational segment.
On May 31, 2003, Aristotle purchased 100% of the outstanding capital stock of Haan Crafts Corporation ("Haan"). Haan is a manufacturer and catalog distributor of sewing kits used in middle school and junior high school family and consumer science classrooms. The acquisition has complemented the Company's current product lines in the educational segment. The results of Haan's operations have been included in the Company's consolidated financial statements since the date of such acquisition. The aggregate purchase price, net of cash acquired, was $5.3 million, including $3.5 million of cash and $1.8 million in seller financing, which was subsequently retired by the Company. The purchase price allocation resulted in goodwill of $3.9 million attributable to the educational segment. In connection with the acquisition of Haan, Aristotle entered into a $1.2 million capital lease with the seller on a building facility ("Haan Building Facility"). On February 12, 2004, the Company settled the capital lease on the Haan Building Facility for $1.1 million.
On May 31, 2003, Aristotle acquired 100% of the outstanding ownership interests in NHI, LLC ("NHI") from Nasco Holdings, Inc. ("Holdings"), a subsidiary of Geneve Corporation ("Geneve"), a privately-held diversified financial holding company. Geneve and Holdings together held more than 90% of Aristotle's outstanding voting stock at September 30, 2004. The sole purpose of NHI is the ownership and management of warehouse and office facilities, which had previously been leased to Aristotle. In connection with the purchase of NHI, Aristotle paid to Holdings an amount equal to the book value of NHI, which included a $3.6 million mortgage related to the properties held by NHI.
On August 6, 2004, the Company paid $3.4 million, including interest, in full settlement of this mortgage.Basic earnings per common share is calculated by dividing net earnings applicable to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per common share is calculated by dividing net earnings applicable to common stockholders by the weighted average number of common shares outstanding during the period and including each share that would have been outstanding assuming the issuance of common shares for all dilutive potential common shares outstanding during the period.
Shares of Common Stock available for issue upon conversion of the 1,096,622 and 1,053,122 shares of Series I Preferred Stock outstanding at September 30, 2004 and 2003, respectively, were not dilutive and, therefore, have not been included in the computations of diluted earnings per common share amounts for the periods then ended.
5
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
During the three and nine months ended September 30, 2004, the Company invested $1.0 million in an investment limited partnership, managed by an affiliate. The Company's investment is accounted for under the equity method of accounting, which equates to the Company's equity in the partnership's underlying book value. The Company's equity income or loss is credited or charged, as appropriate, to the Condensed Consolidated Statements of Earnings.
Changes in stockholders' equity for the nine months ended September 30 are as follows (in thousands):
|
|
2004 |
2003 |
||||||
Balance at January 1 |
$ |
59,844 |
55,718 |
||||||
Net earnings |
14,421 |
10,505 |
|||||||
Exercise of stock options |
212 |
59 |
|||||||
Tax benefit on exercise of stock options |
15 |
- |
|||||||
Stock option compensation |
369 |
397 |
|||||||
Other comprehensive earnings (loss): |
|||||||||
Foreign currency translation adjustment |
208 |
(17) |
|||||||
Preferred dividends |
(6,479) |
(6,450) |
|||||||
Balance at September 30 |
$ |
68,590 |
60,212 |
Comprehensive earnings for the three and nine months ended September 30 is as follows (in thousands):
Three Months Ended |
Nine Months Ended |
|||||||
September 30, |
September 30, |
|||||||
|
|
2004 |
2003 |
2004 |
2003 |
|||
Net earnings |
$ |
7,618 |
5,207 |
14,421 |
10,505 |
|||
Foreign currency translation adjustment |
547 |
95 |
208 |
(17) |
||||
Comprehensive earnings |
$ |
8,165 |
5,302 |
14,629 |
10,488 |
The Company accounts for its stock options under the fair value-based recognition and measurement provisions of Statement of Financial Accounting Standards ("SFAS") No. 123, Accounting for Stock-Based Compensation ("SFAS 123"), which requires the fair value of stock options granted to employees to be measured at the date of grant and recognized as an expense over the service period, which is usually the vesting period of the grant. Under SFAS 123, the Company recognizes the fair value of stock options as an expense within its Condensed Consolidated Statements of Earnings.
6
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
The Company has a 1997 Employee and Director Stock Plan ("1997 Plan") and 2002 Employee, Director and Consultant Stock Plan ("2002 Plan"). The Company does not currently intend to grant any additional options under the 1997 Plan. No stock options were granted under the 2002 Plan during the three months ended September 30, 2004 and 2003. The total estimated fair value of the options granted under the 2002 Plan during the nine months ended September 30, 2004 and 2003 was less than $.1 million and $.4 million, respectively. The total estimated fair value of options granted under the 2002 Plan is generally recognized as non-cash compensation expense over the three year vesting period for such options. The Company recorded compensation expense related to granted stock options of approximately $.2 million and $.1 million for the three months ended September 30, 2004 and 2003, respectively. The Company recorded compensation expense related to granted stock options of approximately $.4 milli on for the nine months ended September 30, 2004 and 2003. The expected annual impact of the options granted to date on 2004 earnings before income taxes is a reduction of approximately $.5 million.
The Company had noncontributory defined benefit pension plans covering substantially all salaried and hourly employees. On September 10, 2004, the Company merged both of the pension plans with a pension plan of an affiliate. As a result of the merger, the Company expects to realize a benefit in net plan assets, the amount of which has not yet been determined by the Company, and anticipates no material change in the future periodic benefit cost of the plan. The Company has not modified the plan benefits provided to employees covered under the plan.
The Company contributed $.4 million and $.1 million to the pension plans for the three months ended September 30, 2004 and 2003, respectively. The Company contributed $.4 million and $.2 million to the pension plans for the nine months ended September 30, 2004 and 2003, respectively. The Company does not plan to make contributions to the pension plan in the fourth quarter of 2004.
The following table presents the components of net periodic benefit cost for the three and nine months ended September 30 (in thousands):
Three Months Ended |
Nine Months Ended |
|||||||||
September 30, |
September 30, |
|||||||||
2004 |
2003 |
2004 |
2003 |
|||||||
Service cost |
$ |
157 |
137 |
469 |
411 |
|||||
Interest cost |
203 |
190 |
609 |
569 |
||||||
Expected return on plan assets |
(212) |
(197) |
(636) |
(591) |
||||||
Amortization of transition asset |
(7) |
(10) |
(20) |
(30) |
||||||
Amortization of prior service cost |
(1) |
- |
(2) |
(2) |
||||||
Recognized net actuarial loss |
53 |
38 |
161 |
116 |
||||||
Net periodic benefit cost |
$ |
193 |
158 |
581 |
473 |
7
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
The Company's business activities are organized into two business segments, educational and commercial. The educational segment relates to instructional teaching aids and materials, which are distributed to educational institutions principally in North America, for kindergarten through grade 12 classes, and for nursing school and emergency medical instructors. Products in the educational segment are marketed primarily through catalogs. The growth potential of the educational segment is directly related to school enrollments and the strength of government funding of education. The commercial segment relates to agricultural products, sterile sampling containers and systems, materials for nursing home activities and novelty and gift products. Products in the commercial segment are marketed through catalogs nationwide and through a worldwide dealer network covering more than 60 countries. Market growth in the commercial segment is principally impacted by the general e conomic conditions of world agriculture, the increasing size of the aged population, as well as increasing global awareness of food and water quality standards. The Company evaluates the performance of these segments based on segment net sales and gross profit.
The following table presents segment information for the three and nine months ended September 30 (in thousands):
Three Months Ended |
Nine Months Ended |
|||||||||
September 30, |
September 30, |
|||||||||
|
|
2004 |
2003 |
2004 |
2003 |
|||||
Net sales: |
|
|
|
|
||||||
|
Educational |
$ |
48,559 |
45,522 |
120,119 |
111,356 |
||||
|
Commercial |
|
7,796 |
7,478 |
23,653 |
22,491 |
||||
|
Intercompany |
|
(987) |
(1,047) |
(4,772) |
(3,492) |
||||
|
|
Net sales |
$ |
55,368 |
51,953 |
139,000 |
130,355 |
|||
Gross profit: |
|
|||||||||
|
Educational |
$ |
18,612 |
17,901 |
46,691 |
43,525 |
||||
|
Commercial |
|
2,902 |
2,716 |
8,678 |
8,145 |
||||
|
Other costs of sales |
|
(1,345) |
(1,256) |
(3,180) |
(2,844) |
||||
|
|
Gross profit |
$ |
20,169 |
19,361 |
52,189 |
48,826 |
Other costs of sales primarily include freight costs incurred in the procurement of inventories and shipment of customer orders not allocable to a particular segment.
8
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2004
(Unaudited)
The following table presents segment identifiable asset information as of September 30, 2004, December 31, 2003 and September 30, 2003 (in thousands):
September 30, |
|
December 31, |
September 30, |
|||||
2004 |
2003 |
2003 |
||||||
Identifiable assets: |
|
|
|
|||||
|
Educational |
$ |
52,122 |
45,606 |
45,857 |
|||
|
Commercial |
|
5,658 |
4,624 |
5,230 |
|||
|
Other corporate assets |
|
59,341 |
54,884 |
65,739 |
|||
|
|
Identifiable assets |
$ |
117,121 |
105,114 |
116,826 |
Educational assets include $13.5 million, $11.5 million and $10.9 million of goodwill at September 30, 2004, December 31, 2003 and September 30, 2003, respectively.
The following table presents supplemental cash flow information for the nine months ended September 30 (in thousands):
Nine Months Ended |
|||||||||||||
September 30, |
|||||||||||||
|
|
2004 |
2003 |
||||||||||
Cash paid during the period for: |
|||||||||||||
Interest |
$ |
950 |
1,120 |
||||||||||
Income taxes |
1,373 |
1,953 |
|||||||||||
Non-cash investing and financing activities: |
|||||||||||||
Notes payable and capital lease executed in |
|||||||||||||
connection with acquisitions |
- |
7,062 |
|||||||||||
Net assets from acquisitions: |
|||||||||||||
Net working capital |
1,104 |
1,065 |
|||||||||||
Property, plant and equipment |
135 |
5,546 |
|||||||||||
Goodwill |
1,951 |
3,900 |
|||||||||||
Deferred income taxes |
404 |
- |
|||||||||||
Other assets |
135 |
- |
|||||||||||
Long-term debt |
- |
(7,062) |
|||||||||||
Total cash paid for acquisitions, |
|||||||||||||
net of cash acquired |
$ |
3,729 |
3,449 |
9
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
GENERAL
This discussion and analysis of financial condition and results of operations reviews the results of operations of the Company, on a consolidated basis, for the three and nine months ended September 30, 2004 as compared to the three and nine months ended September 30, 2003. This discussion and analysis of financial condition and results of operations has been derived from, and should be read in conjunction with, the unaudited Condensed Consolidated Financial Statements and Notes to Condensed Consolidated Financial Statements contained herein.
The Company is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products, primarily offered through catalogs.
The following is a summary of key events for the three and nine months ended September 30, 2004:
A key strength of the Company's business is its ability to generate cash consistently. The Board of Directors and management use cash generated as a measure of the Company's performance. The Company uses the cash generated from operations to strengthen the balance sheet, including reducing liabilities such as pensions and debt, paying dividends on its preferred stock and taking advantage of prudent acquisition opportunities. The Company's management believes that looking at the ability to generate cash provides investors with additional insight into the Company's performance.
10
The following table sets forth selected financial data (i) as a percentage of net sales for the three and nine months ended September 30, 2004 and 2003 and (ii) the percentage change in dollars in those reported items from the comparable period in 2003:
Three Months Ended September 30, |
Nine Months Ended September 30, |
||||||||||||||
2004 |
2003 |
% Change |
2004 |
2003 |
% Change |
||||||||||
Net sales |
100.0 |
% |
100.0 |
% |
6.6 |
% |
100.0 |
% |
100.0 |
% |
6.6 |
% |
|||
Cost of sales |
63.6 |
62.7 |
8.0 |
62.5 |
62.5 |
6.5 |
|||||||||
Gross profit |
36.4 |
37.3 |
4.2 |
37.5 |
37.5 |
6.9 |
|||||||||
Selling and administrative expense |
19.7 |
19.9 |
5.5 |
22.4 |
23.3 |
2.4 |
|||||||||
Earnings from operations |
16.7 |
17.4 |
2.7 |
15.1 |
14.2 |
14.3 |
|||||||||
Other expense (income): |
|||||||||||||||
Interest expense |
.5 |
.9 |
(35.4) |
.6 |
.9 |
(21.0) |
|||||||||
Other, net |
(.1) |
- |
310.0 |
- |
- |
(69.2) |
|||||||||
.4 |
.9 |
(43.2) |
.6 |
.9 |
(18.0) |
||||||||||
Earnings before income taxes |
16.3 |
16.5 |
5.0 |
14.5 |
13.3 |
16.3 |
|||||||||
Income taxes |
|||||||||||||||
Current |
1.8 |
1.6 |
22.3 |
1.5 |
1.4 |
13.2 |
|||||||||
Deferred |
.7 |
5.0 |
(84.0) |
2.7 |
3.8 |
(26.5) |
|||||||||
2.5 |
6.6 |
(58.3) |
4.2 |
5.2 |
(16.0) |
||||||||||
Net earnings |
13.8 |
% |
9.9 |
% |
46.3 |
10.3 |
8.1 |
% |
37.3 |
Three Months Ended |
Nine Months Ended |
|||||||||
September 30, |
September 30, |
|||||||||
2004 |
2003 |
2004 |
2003 |
|||||||
Net earnings |
$ |
7,618 |
5,207 |
14,421 |
10,505 |
|||||
Add: |
||||||||||
Income taxes |
1,415 |
3,393 |
5,724 |
6,818 |
||||||
Interest expense and other income |
251 |
442 |
874 |
1,066 |
||||||
Depreciation and amortization |
488 |
478 |
1,348 |
1,336 |
||||||
EBITDA |
$ |
9,772 |
9,520 |
22,367 |
19,725 |
11
FLUCTUATIONS IN QUARTERLY RESULTS OF OPERATIONS
The Company is subject to seasonal influences with peak levels occurring in the second and third quarters of the fiscal year primarily due to increased educational shipments coinciding with the Fall start of new school years. As a result, the Company recognizes approximately 75% of its annual net earnings in the second and third quarters of its fiscal year. Inventory levels increase in March through June in anticipation of the peak shipping season. The majority of shipments are made between June and August and the majority of cash receipts are collected from August through October.
Quarterly results may also be materially affected by the timing of acquisitions, the timing and magnitude of costs related to such acquisitions, variations in costs of products sold, the mix of products sold and general economic conditions. Results for any quarter are not indicative of the results for any subsequent fiscal quarter or for a full fiscal year.
RESULTS OF OPERATIONS - THREE MONTHS ENDED SEPTEMBER 30, 2004 AS COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2003
Net Sales
Net sales for the third quarter of 2004 increased 6.6% to $55.4 million from $52.0 million for the comparable period in 2003. The growth in net sales for the third quarter of 2004 is primarily attributable to organic growth and the overall stabilization of general national and international economic conditions compared to the volatility in the U.S. economy and budget uncertainty in the U.S. education sector which had affected the Company in the third quarter of 2003. Net sales in the educational segment, totaling $48.5 million, increased 6.7% in the third quarter of 2004 from $45.6 million in the third quarter of 2003. The commercial segment recorded net sales of $7.8 million in the third quarter of 2004 as compared to $7.5 million in the third quarter of 2003, increasing 4.3% versus the prior year.
Gross Profit
Gross profit for the third quarter of 2004 increased 4.2% to $20.2 million from $19.3 million for the third quarter of 2003. The increase in gross profit for the third quarter of 2004 is primarily attributable to the 6.6% increase in net sales. Gross profit margin of 36.4% in the third quarter 2004 decreased from the 37.3% gross profit margin in the third quarter of 2003. Gross profit margin decreased as a result of a shift in the sales mix to lower margin quote business primarily in the educational segment. The educational segment yielded a gross profit of $18.6 million in the third quarter of 2004, improving on the third quarter of 2003 gross profit of $17.9 million. The educational segment gross profit margin decreased to 38.3% in the third quarter of 2004 from 39.3% for the comparable period in 2003. The commercial segment gross profit for the third quarter of 2004 increased 6.8% to $2.9 million from $2.7 million for the comparable period in 2003. The commercial segment yielded a gross profit margin of 37.2% in the third quarter of 2004, as compared to 36.3% in the third quarter of 2003.
Selling and Administrative Expenses
Selling and administrative expenses for the third quarter of 2004 increased 5.5% to $10.9 million from $10.3 million in the comparable period in 2003. As a percent of net sales, selling and administrative expenses decreased to 19.7% in the third quarter of 2004 from 19.9% in the third quarter of 2003. Expenses included in this total include advertising and catalog costs, warehouse and shipping activities, customer service and general administrative functions. Selling and administrative expenses for the third quarter of 2004 were impacted by the following: (i) increase in salaries and wages of $.5 million as a result of annual employee compensation increases and employee performance incentives and (ii) an increase in group health costs by 31.0% to $.9 million in the third quarter of 2004.
The Company recorded $.2 million and $.1 million in compensation expense for the third quarters of 2004 and 2003, respectively, related to grants of stock options to certain employees and directors.
The Company incurred expenses of $.2 million to Geneve for certain administrative services for the third quarters of 2004 and 2003.
12
Interest Expense
Interest expense decreased 35.4% to $.3 million for the third quarter of 2004, compared to $.5 million for the same period in 2003. The decrease in interest expense is due to the decline in the weighted average interest rate on the Company's debt to 3.5% in the third quarter of 2004 compared to 3.8% in the third quarter of 2003 and a decrease in the weighted average debt outstanding during the third quarter of 2004 compared to the same period in 2003 as a result of the following: (i) decrease in the amounts outstanding on the Company's primary credit facility; (ii) total payments of $3.8 million during the fourth quarter of 2003 in full settlement of a note payable and seller financing related to the acquisition of Haan; (iii) payment of $1.1 million during the first quarter of 2004 for the full settlement of capital lease obligations related to the Haan Building Facility; (iv) payment in full of the $.5 million note payable to a related party during the second quarter of 2004; and (v) payment of $3.4 million during the third quarter of 2004 in full settlement of the mortgage related to the properties held by NHI
. The Company's credit agreements assessed interest at a weighted average rate of 3.4%, 3.6% and 3.6% at September 30, 2004, December 31, 2003 and September 30, 2003, respectively.Income Tax Provision
Aristotle and its qualifying domestic subsidiaries are included in the Federal income tax return and certain state income tax returns of Geneve. The provision for income taxes for the Company is determined on a separate return basis in accordance with the terms of a tax sharing agreement with Geneve, and payments for current Federal and certain state income taxes are made to Geneve.
The income tax provision for the third quarter of 2004 was $1.4 million compared to $3.4 million for the comparable period in 2003. These tax provisions reflect effective tax rates of 15.7% and 39.5% for the third quarters of 2004 and 2003, respectively. For the third quarter of 2004, the difference between the Federal statutory income tax rate of 35% and the effective income tax rate results principally from reductions in the valuation allowance amounting to $1.4 million primarily related to increased estimates of projected taxable income, increases to other net deferred tax assets amounting to $.8 million, foreign income taxes and state income taxes,. For the third quarter of 2003, the difference between the Federal statutory income tax rate of 35% and the effective income tax rate results principally from foreign and state income taxes. Approximately $2.6 million of the income tax provision for the third quarters of 2004 and 2003 relates to the curre nt utilization of the Company's Federal net operating tax loss carryforwards. Although the reported earnings for the third quarters of 2004 and 2003 are shown after-tax, approximately $2.6 million of cash from operations was retained in the Company primarily as a result of the current utilization of these Federal net operating tax loss carryforwards. Except for Federal alternative minimum tax obligations arising from limitations on the utilization of Federal net operating tax loss carryforwards in 2004 and future years, the Company anticipates that the utilization of the available Federal net operating tax loss carryforwards to offset future Federal taxable income will result in the Company not having to use its cash resources to pay Federal income taxes through 2006.
At September 30, 2004, the Condensed Consolidated Balance Sheet contains a net deferred tax asset of $20.2 million, net of a valuation allowance of $8.9 million. Substantially all of the net deferred tax asset relates to Federal net operating tax loss carryforwards. The valuation allowance has been established primarily to reflect the estimate of Federal net operating tax loss carryforwards that are expected to expire unutilized. The valuation allowance decreased $2.1 million in the third quarter of 2004. In accordance with SFAS No. 109 Accounting for Income Taxes ("SFAS 109"), $.7 million of this decrease in the valuation allowance in the third quarter of 2004 was recognized as a reduction to goodwill of CPR Prompt and Ginsberg as a result of the increased projected Federal taxable income provided by these acquisitions. The remaining $1.4 million decrease in the valuation allowance in the third quarter of 2004 was primarily related to the following: (i) $1.6 million decrease in the valuation allowance due to other increased estimates of projected Federal taxable income; and (ii) $.2 million increase in the valuation allowance related to the inability to realize other deferred tax assets. The Company now believes it is more likely than not that certain of these Federal net operating tax loss carryforwards will be utilized. There was no change in the valuation allowance during the third quarter of 2003.
13
RESULTS OF OPERATIONS - NINE MONTHS ENDED SEPTEMBER 30, 2004 AS COMPARED TO NINE MONTHS ENDED SEPTEMBER 30, 2003
Net Sales
Net sales for the nine months ended September 30, 2004 increased 6.6% to $139.0 million from $130.4 million for the comparable period in 2003. The growth in net sales for the first nine months of 2004 is positively impacted by the inclusion of an additional $2.8 million of net sales from the Haan, CPR Prompt and Ginsberg acquisitions, organic growth of approximately 4.6% and the overall stabilization of general national and international economic conditions compared to the volatility in the U.S. economy and budget uncertainty in the U.S. education sector which had affected the Company in the comparable period in 2003. Net sales in the educational segment, totaling $120.1 million, increased 7.9% in the first nine months of 2004 from $111.4 million in the first nine months of 2003. Excluding the net sales from Haan, CPR Prompt and Ginsberg, educational segment net sales increased 5.4% from the first nine months of 2003. The commercial segment recorded net sales of $23.6 million in the first nine months of 2004 as compared to $22.5 million in the first nine months of 2003, increasing 5.2% versus the prior year.
Gross Profit
Gross profit for the nine months ended September 30, 2004 increased 6.9% to $52.2 million as compared to $48.8 million for the comparable period in 2003. The increase in gross profit for the first nine months of 2004 is primarily attributable to the 6.6% increase in net sales and the additional contribution to gross profit of $1.2 million made by Haan, CPR Prompt and Ginsberg. Gross profit margin of 37.5% in the first nine months of 2004 remained consistent with the gross profit margin in the first nine months of 2003. The educational segment yielded a gross profit of $46.7 million in the first nine months of 2004, improving on the first nine months of 2003 gross profit of $43.5 million. The educational segment gross profit margin of 38.9% in the first nine months of 2004 remained consistent with the comparable period in 2003. The commercial segment gross profit for the first nine months of 2004 increased 6.5% to $8.7 million from $8.1 million for the comparable period in 2003. The commercial segment gross profit margin in the first nine months of 2004 increased to 36.7% from 36.2% in the comparable period in 2003.
Selling and Administrative Expenses
Selling and administrative expenses of $31.2 million for the nine months ended September 30, 2004 increased 2.4% from the comparable period in 2003 while net sales increased 6.6%. As a percent of net sales, selling and administrative expenses decreased to 22.4% in the first nine months of 2004 from 23.3% in the first nine months of 2003. Expenses included in this total include advertising and catalog costs, warehouse and shipping activities, customer service and general administrative functions. Selling and administrative expenses for the first nine months of 2004 were impacted by the following: (i) inclusion of an additional $.3 million in expenses of Haan, CPR Prompt and Ginsberg in operations for the first nine months of 2004; (ii) increase in salaries and wages of $1.2 million as a result of annual employee compensation increases and employee performance incentives; and (iii) an increase in group health costs by 2.9% to $2.5 million in the first nine months of 2004.
The Company recorded $.4 million in compensation expense for the first nine months of 2004 and 2003 related to grants of stock options to certain employees and directors.
The Company incurred expenses of $.6 million to Geneve for certain administrative services for the first nine months of 2004 and 2003.
Interest Expense
Interest expense decreased 21.0% to $.9 million for the nine months ended September 30, 2004, compared to $1.1 million for the same period in 2003. The decrease in interest expense is due to the decline in the weighted average interest rate on the Company's debt to 3.5% in the first nine months of 2004 compared to 3.6% in the first nine months of 2003 and a decrease in the weighted average debt outstanding during the first nine months of 2004 compared to the same period in 2003 as a result of the following: (i) decrease in the amounts outstanding on the Company's primary credit facility; (ii) total payments of $3.8 million during the fourth quarter of 2003 in full settlement of a note payable and seller financing related to the acquisition of Haan; (iii) payment of $1.1 million during the first quarter of 2004 for the full settlement of capital lease obligations related to the Haan Building Facility; (iv) payment in full of the $.5 million note payable to a related party during the second quarter of 2004; and (v) payment of $3.4 million during the third quarter of 2004 in full settlement of the mortgage related to the properties held by NHI
. The Company's credit agreements assessed interest at a weighted average rate of 3.4%, 3.6% and 3.6% at September 30, 2004, December 31, 2003 and September 30, 2003, respectively.14
Income Tax Provision
Aristotle and its qualifying domestic subsidiaries are included in the Federal income tax return and certain state income tax returns of Geneve. The provision for income taxes for the Company is determined on a separate return basis in accordance with the terms of a tax sharing agreement with Geneve, and payments for current Federal and certain state income taxes are made to Geneve.
The income tax provision for the nine months ended September 30, 2004 was $5.7 million compared to $6.8 million for the comparable period in 2003. These tax provisions reflect effective tax rates of 28.4% and 39.4% for the first nine months of 2004 and 2003, respectively. For the first nine months of 2004, the difference between the Federal statutory income tax rate of 35% and the effective income tax rate results principally from reductions in the valuation allowance amounting to $1.4 million primarily related to increased estimates of projected taxable income, increases to other net deferred tax assets amounting to $.8 million, foreign income taxes and state income taxes. For the first nine months of 2003, the difference between the Federal statutory income tax rate of 35% and the effective income tax rate results principally from foreign and state income taxes. Approximately $5.9 million of the income tax provision for the first nine months of 2004 r elates to the current utilization of the Company's Federal net operating tax loss carryforwards compared to approximately $5.0 million in the first nine months of 2003. Although the reported earnings for the first nine months of 2004 and 2003 are shown after-tax, approximately $5.9 million and $5.0 million, respectively, of cash from operations was retained in the Company primarily as a result of the current utilization of these Federal net operating tax loss carryforwards. Except for Federal alternative minimum tax obligations arising from limitations on the utilization of Federal net operating tax loss carryforwards in 2004 and future years, the Company anticipates that the utilization of the available Federal net operating tax loss carryforwards to offset future Federal taxable income will result in the Company not having to use its cash resources to pay Federal income taxes through 2006.
At September 30, 2004, the Condensed Consolidated Balance Sheet contains a net deferred tax asset of $20.2 million, net of a valuation allowance of $8.9 million. Substantially all of the net deferred tax asset relates to Federal net operating tax loss carryforwards. The valuation allowance has been established primarily to reflect the estimate of Federal net operating tax loss carryforwards that are expected to expire unutilized. The valuation allowance decreased $2.1 million in the first nine months of 2004. In accordance with SFAS 109, $.7 million of this decrease in the valuation allowance in the first nine months of 2004 was recognized as a reduction to goodwill of CPR Prompt and Ginsberg as a result of the increased projected Federal taxable income provided by these acquisitions. The remaining $1.4 million decrease in the valuation allowance in the first nine months of 2004 was primarily related to the following: (i) $1.6 million decrease in the valuation allowance due to other increased estimates of projected Federal taxable income; and (ii) $.2 million increase in the valuation allowance related to the inability to realize other deferred tax assets. The Company now believes it is more likely than not that certain of these Federal net operating tax loss carryforwards will be utilized. There was no change in the valuation allowance during the first nine months of 2003.
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 2004, the Company had working capital of $59.2 million, increasing from $46.8 million at December 31, 2003. At September 30, 2003, the Company had working capital of $56.7 million. Cash and cash equivalents decreased $1.4 million in the first nine months of 2004, ending the period at $4.2 million. Cash and cash equivalents decreased $4.2 million in first nine months of 2003, ending the period at $7.1 million. This decrease in the use of cash and cash equivalents during the first nine months of 2004 as compared to the same period in 2003 is primarily due to the following activities:
15
These changes in current assets and liabilities are typical for the first nine months of the fiscal year as the Company is preparing for its peak business cycle, which occurs during the second and third quarters of the fiscal year. For more information on the seasonality of the Company's business, please refer to the "Fluctuations in Quarterly Results of Operations" section above.
The Company paid dividends of $8.6 million in the first nine months of 2004 and 2003 on its Series I Preferred Stock and Series J Preferred Stock issued on June 17, 2002.
On October 15, 2003, the Company entered into a five-year, non-amortizing, $45.0 million Revolving Credit Facility. Proceeds from the Revolving Credit Facility were initially used to extinguish the $31.2 million in borrowings outstanding under the then-existing credit facility and $2.2 million in notes payable of the Company. The Revolving Credit Facility will provide the Company with seasonal working capital, letters of credit and funds for appropriate acquisitions of businesses similar in nature to the Company's current business segments. This debt carries a variable rate of interest that is based on Prime or LIBOR rates plus applicable margins. At September 30, 2004, the weighted average interest rate on this debt was 3.2%. The Revolving Credit Facility currently has a committed weighted average rate of interest (including applicable margins) of approximately 3.1%. Such rate commitments expire on various dates through November 26, 2004. The Company's Revolving Credit Facility is collateralized by certain accounts receivable, inventories and property, plant and equipment, and shares of a certain subsidiary's capital stock outstanding and ownership interests of certain of the Company's limited liability subsidiaries. The Revolving Credit Facility contains various financial and operating covenants, including, among other things, requirements to maintain certain financial ratios and restrictions on additional indebtedness, common stock dividend payments, capital disposals and intercompany management fee s. The Company was in compliance with all financial covenants as of September 30, 2004.
Capital resources in the future are expected to be used for the development of catalogs and product lines, to acquire additional businesses and for other investing activities. The Company anticipates that there will be sufficient financial resources to meet projected working capital and other cash requirements for at least the next twelve months. Management of the Company believes it has sufficient capacity to maintain current operations and support a substantial amount of future growth.
SIGNIFICANT ACCOUNTING POLICIES
The Company believes the following accounting policies affect the more significant judgments and estimates used in the preparation of the Condensed Consolidated Financial Statements:
Prepaid Catalog Costs and Amortization - The Company accumulates all direct costs, less vendor rebates, incurred in the development, production and circulation of catalogs on the Condensed Consolidated Balance Sheets until the related catalog is mailed, at which time such catalog costs are amortized into selling and administrative expense over the estimated sales realization cycle of one year, using the straight-line method.
16
Deferred Income Taxes - At September 30, 2004, the Condensed Consolidated Balance Sheet contains a net deferred tax asset of approximately $20.2 million, net of a valuation allowance of approximately $8.9 million, related primarily to Federal net operating tax loss carryforwards. The realizability of this asset is dependent upon the Company's generation of approximately $60 million in future taxable income and the ability to retain its Federal net operating tax loss carryforward position. Events may limit the use of all or a portion of these Federal net operating tax loss carryforwards, thus potentially resulting in a higher tax liability for the Company in the future. The net deferred tax asset, including the valuation allowance, at September 30, 2004 is subject to future adjustment based upon changes in management's evaluation of the realizability of the deferred tax asset.
Goodwill - The Company evaluates goodwill for impairment at least annually or more frequently if events or circumstances indicate that the assets may be impaired, by applying a fair value based test and, if impairment occurs, the amount of impaired goodwill is written off immediately. The Company evaluates goodwill for impairment based on the expected future cash flows or earnings projections. Goodwill is deemed impaired if the estimated discounted cash flows or earnings projections do not substantiate the carrying value. The estimation of such amounts requires significant management judgment with respect to revenue and expense growth rates, changes in working capital and selection of an appropriate discount rate, as applicable. The use of different assumptions would increase or decrease discounted future operating cash flows or earnings projections and could, therefore, change impairment determination. The Company has evaluated its goodwill at December 31, 2003, and determined th at there has been no impairment of goodwill.
Defined Benefit Plans
- The Company accounts for the benefits under its salaried and hourly defined benefit pension plans using actuarial models required by SFAS No. 87, "Employers' Accounting for Pensions." These models use an attribution approach that generally spreads individual events over the service lives of the employees in the plans. Examples of "events" are plan amendments and changes in actuarial assumptions such as discount rate, expected return on plan assets and rate of compensation increases. The principle underlying the required attribution approach is that employees render service over their service lives on a relatively consistent basis and, therefore, the statement of earnings effects of pension benefits are earned in, and should be expensed in, the same pattern.In calculating net periodic benefit cost and the related benefit obligation, the Company is required to select certain actuarial assumptions. These assumptions include discount rate, expected return on plan assets and rate of compensation increase. The discount rate assumptions reflect the prevailing market rates for long-term, high-quality, fixed-income debt instruments that, if the obligation was settled at the measurement date, would provide the necessary future cash flows to pay the benefit obligation when due. The Company uses long-term historical actual return experience with consideration of the expected investment mix of the plans' assets, as well as future estimates of long-term investment returns, to develop its assumptions of the expected return on plan assets. The rate of compensation increase is based on historical experience and the Company's long-term plans for such increases.
Revenues - Customarily applying FOB-shipping point terms, the Company recognizes revenue upon shipment of products to its customer, which corresponds to the time when risk of ownership transfers. The point of shipment is typically from one of the Company's distribution centers or, on occasion, a vendor's location as a drop shipment. All drop shipment sales are recorded at gross selling price.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As described below, credit risk and interest rate risk are the primary sources of market risk in the Company's accounts receivable and long-term borrowings, respectively.
QUALITATIVE
Credit Risk: The Company provides credit in the normal course of business to its customers, which are primarily educational institutions or distributors. No single customer accounted for more than 10% of sales in the first nine months of 2004 and 2003. The Company performs ongoing credit evaluations of its customers, maintains allowances for potential credit losses and generally does not require collateral to support its accounts receivable balances.
17
Interest Rate Risk: Changes in interest rates can potentially impact the Company's profitability and its ability to realize assets and satisfy liabilities. Interest rate risk is resident primarily in long-term borrowings, which typically have variable interest rates based on Prime or LIBOR rates. Assuming no other change in financial structure, an increase of 1% in the Company's variable interest rate for long-term borrowings would decrease earnings before income taxes for 2004 by approximately $.3 million. This amount is determined by considering a 1% increase in interest rates on the average long-term borrowings estimated to be outstanding in 2004.
QUANTITATIVE
The Company's long-term borrowings as of September 30, 2004 are as follows (in millions, except percentage data):
MATURITY LESS THAN ONE YEAR |
MATURITY GREATER THAN ONE YEAR |
||||||
Amount |
$ |
.1 |
$ |
32.9 |
|||
Weighted average interest rate |
4.9% |
3.3% |
|||||
Fair market value |
$ |
.1 |
$ |
32.9 |
The fair market value of long-term borrowings equals the face amount of long-term borrowings outstanding because the underlying rate of interest on substantially all of the Company's debt is variable based upon Prime or LIBOR rates.
ITEM 4. CONTROLS AND PROCEDURES
The President and the Chief Financial Officer of the Company (its principal executive officer and its principal financial officer, respectively) have concluded, based on their evaluation as of the end of the period covered by this Report, that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed or submitted by it under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's ("SEC") rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company's management, including the President and the Chief Financial Officer, as appropriate, and allow timely decisions regarding required disclosure.
There have not been any changes in the Company's internal control over financial reporting during the fiscal quarter ended September 30, 2004 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
FORWARD-LOOKING STATEMENTS
The Company believes that this Quarterly Report on Form 10-Q may contain forward-looking statements within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those projected or suggested in such forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors including, but not limited to, the following: (i) the ability of the Company to obtain financing and additional capital to fund its business strategy on acceptable terms, if at all; (ii) the ability of the Company on a timely basis to find, prudently negotiate and consummate additional acquisitions; (iii) the ability of the Company to manage any to-be acquired businesses; (iv) the ability of the Company to retain and utilize its Federal net operating tax loss carryforward position; and (v) general economic conditions. As a result, the Company's future development efforts involve a high degree of risk. For further information, please see the Company's filings with the SEC, including its Forms 10-K, 10-Q and 8-K.
Reference is also made to the risk factors set forth in the final prospectus which constitutes a portion of the Company's Registration Statement on Form S-4 (Commission File No. 333-86026), which was filed in connection with the merger with Nasco International, Inc.
18
PART II
ITEM 6. EXHIBITS
See Page 21 for the Exhibit index.
19
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 10, 2004
&n bsp; /s/ Steven B. Lapin
Steven B. Lapin
President and Chief Operating Officer
(Principal Executive Officer)
Date: November 10, 2004
/s/ Dean T. Johnson
Dean T. Johnson
&n bsp; Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
20
EXHIBIT INDEX |
||
EXHIBIT NUMBER |
DESCRIPTION |
|
31.1 |
Rule 13a-14(a)/15d-14(a) Certifications. |
|
31.2 |
Rule 13a-14(a)/15d-14(a) Certifications. |
|
32.1 |
Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|
32.2 |
Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
21